Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer.

Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S, Croce CM.

Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4908-13. doi: 10.1073/pnas.1101795108. Epub 2011 Mar 7.

2.

Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization.

Donnem T, Eklo K, Berg T, Sorbye SW, Lonvik K, Al-Saad S, Al-Shibli K, Andersen S, Stenvold H, Bremnes RM, Busund LT.

J Transl Med. 2011 Jan 10;9:6. doi: 10.1186/1479-5876-9-6.

3.

MicroRNA regulation of ionizing radiation-induced premature senescence.

Wang Y, Scheiber MN, Neumann C, Calin GA, Zhou D.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):839-48. doi: 10.1016/j.ijrobp.2010.09.048. Epub 2010 Nov 17.

4.

Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis.

Ghosh G, Subramanian IV, Adhikari N, Zhang X, Joshi HP, Basi D, Chandrashekhar YS, Hall JL, Roy S, Zeng Y, Ramakrishnan S.

J Clin Invest. 2010 Nov;120(11):4141-54. doi: 10.1172/JCI42980. Epub 2010 Oct 25.

5.

The VHL-dependent regulation of microRNAs in renal cancer.

Neal CS, Michael MZ, Rawlings LH, Van der Hoek MB, Gleadle JM.

BMC Med. 2010 Oct 21;8:64. doi: 10.1186/1741-7015-8-64.

6.

The tumor microenvironment in non-small-cell lung cancer.

Graves EE, Maity A, Le QT.

Semin Radiat Oncol. 2010 Jul;20(3):156-63. doi: 10.1016/j.semradonc.2010.01.003. Review.

7.

MiR-210--micromanager of the hypoxia pathway.

Huang X, Le QT, Giaccia AJ.

Trends Mol Med. 2010 May;16(5):230-7. doi: 10.1016/j.molmed.2010.03.004. Epub 2010 Apr 29. Review.

8.

MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer.

Kong W, He L, Coppola M, Guo J, Esposito NN, Coppola D, Cheng JQ.

J Biol Chem. 2010 Jun 4;285(23):17869-79. doi: 10.1074/jbc.M110.101055. Epub 2010 Apr 6. Retraction in: J Biol Chem. 2016 Oct 21;291(43):22855.

9.

Modulation of mismatch repair and genomic stability by miR-155.

Valeri N, Gasparini P, Fabbri M, Braconi C, Veronese A, Lovat F, Adair B, Vannini I, Fanini F, Bottoni A, Costinean S, Sandhu SK, Nuovo GJ, Alder H, Gafa R, Calore F, Ferracin M, Lanza G, Volinia S, Negrini M, McIlhatton MA, Amadori D, Fishel R, Croce CM.

Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6982-7. doi: 10.1073/pnas.1002472107. Epub 2010 Mar 29.

10.

Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis.

Yan HL, Xue G, Mei Q, Wang YZ, Ding FX, Liu MF, Lu MH, Tang Y, Yu HY, Sun SH.

EMBO J. 2009 Sep 16;28(18):2719-32. doi: 10.1038/emboj.2009.214. Epub 2009 Aug 20.

11.

Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival.

Greither T, Grochola LF, Udelnow A, Lautenschläger C, Würl P, Taubert H.

Int J Cancer. 2010 Jan 1;126(1):73-80. doi: 10.1002/ijc.24687.

12.

Role of hypoxia in the hallmarks of human cancer.

Ruan K, Song G, Ouyang G.

J Cell Biochem. 2009 Aug 15;107(6):1053-62. doi: 10.1002/jcb.22214. Review.

PMID:
19479945
13.

MicroRNA regulation of DNA repair gene expression in hypoxic stress.

Crosby ME, Kulshreshtha R, Ivan M, Glazer PM.

Cancer Res. 2009 Feb 1;69(3):1221-9. doi: 10.1158/0008-5472.CAN-08-2516. Epub 2009 Jan 13. Erratum in: Cancer Res. 2009 Apr 1;69(7):3240.

14.

hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.

Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM, Ragoussis J.

Clin Cancer Res. 2008 Mar 1;14(5):1340-8. doi: 10.1158/1078-0432.CCR-07-1755.

15.

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.

Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, Motoo Y, Wang Q, Rocchi P, Russo A, Gleave M, Dagorn JC, Iovanna JL, Carrier A, Pébusque MJ, Dusetti NJ.

Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16170-5. Epub 2007 Oct 2.

16.

Clonogenic assay of cells in vitro.

Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C.

Nat Protoc. 2006;1(5):2315-9.

PMID:
17406473
17.

A microRNA signature of hypoxia.

Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA, Ivan M.

Mol Cell Biol. 2007 Mar;27(5):1859-67. Epub 2006 Dec 28.

18.

Hypoxia signalling in cancer and approaches to enforce tumour regression.

Pouysségur J, Dayan F, Mazure NM.

Nature. 2006 May 25;441(7092):437-43. Review.

PMID:
16724055
19.

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC.

Cancer Cell. 2006 Mar;9(3):189-98.

20.

A microRNA expression signature of human solid tumors defines cancer gene targets.

Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM.

Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61. Epub 2006 Feb 3.

Supplemental Content

Support Center